CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

Econazole 100mg  | ≥99%

CSNpharm

Econazole is an imidazole-derived and broad-spectrum antimycotic agent with fungistatic properties, working by inhibiting biosynthesis of ergosterol, thereby damaging the fungal cell wall membrane and altering its permeability.

More Information Supplier Page

Econazole 25mg  | ≥99%

CSNpharm

Econazole is an imidazole-derived and broad-spectrum antimycotic agent with fungistatic properties, working by inhibiting biosynthesis of ergosterol, thereby damaging the fungal cell wall membrane and altering its permeability.

More Information Supplier Page

Edaravone 5g  | ≥99%

CSNpharm

Edaravone is a free radical scavenger used to help with recovery following a stroke and to treat amyotrophic lateral sclerosis (ALS).

More Information Supplier Page

Edaravone 250mg  | ≥99%

CSNpharm

Edaravone is a free radical scavenger used to help with recovery following a stroke and to treat amyotrophic lateral sclerosis (ALS).

More Information Supplier Page

Eflornithine HCl H2O 50mg  | ≥98%

CSNpharm

Eflornithine HCl is a specific, irreversible inhibitor of the enzyme ornithine decarboxylase, is a medication for the treatment of African trypanosomiasis and excessive facial hair growth in women.

More Information Supplier Page

Eflornithine HCl H2O 100mg  | ≥98%

CSNpharm

Eflornithine HCl is a specific, irreversible inhibitor of the enzyme ornithine decarboxylase, is a medication for the treatment of African trypanosomiasis and excessive facial hair growth in women.

More Information Supplier Page

EG1 5mg  | ≥99%

CSNpharm

EG1 is an inhibitor of Pax2 transcription activation with a small molecule that targets the DNA binding domain.

More Information Supplier Page

EG1 1mg  | ≥99%

CSNpharm

EG1 is an inhibitor of Pax2 transcription activation with a small molecule that targets the DNA binding domain.

More Information Supplier Page

EG1 25mg  | ≥99%

CSNpharm

EG1 is an inhibitor of Pax2 transcription activation with a small molecule that targets the DNA binding domain.

More Information Supplier Page

EG1 50mg  | ≥99%

CSNpharm

EG1 is an inhibitor of Pax2 transcription activation with a small molecule that targets the DNA binding domain.

More Information Supplier Page

EG1 100mg  | ≥99%

CSNpharm

EG1 is an inhibitor of Pax2 transcription activation with a small molecule that targets the DNA binding domain.

More Information Supplier Page

EG1 10mg  | ≥99%

CSNpharm

EG1 is an inhibitor of Pax2 transcription activation with a small molecule that targets the DNA binding domain.

More Information Supplier Page

EGTA 1g  | ≥95%

CSNpharm

EGTA is a calcium chelating agent, it’s also a useful chemical in a variety of buffers. It also inhibits the zinc-dependent endopeptidases, MMPs.

More Information Supplier Page

EIDD-1931 5mg  | ≥99%

CSNpharm

EIDD-1931 has a broad-spectrum antiviral activity against multiple coronaviruses, including SARS-CoV2, MERS-CoV, SARS-CoV. and related zoonotic group 2b or 2c Bat-CoVs, as well as increased potency against a coronavirus bearing resistance mutations to another nucleoside analog inhibitor.

More Information Supplier Page

EIDD-1931 10mg  | ≥99%

CSNpharm

EIDD-1931 has a broad-spectrum antiviral activity against multiple coronaviruses, including SARS-CoV2, MERS-CoV, SARS-CoV. and related zoonotic group 2b or 2c Bat-CoVs, as well as increased potency against a coronavirus bearing resistance mutations to another nucleoside analog inhibitor.

More Information Supplier Page